Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma

Human Molecular Genetics

Volumn 22, Issue 6, 2013, Pages 1262-1269

  Zhang, Tongwen ^a   Cai, Jianqiang ^a   Chang, Jiang ^a   Yu, Dianke ^a   Wu, Chen ^a   Yan, Tao ^a   Zhai, Kan ^a   Bi, Xinyu ^a   Zhao, Hong ^a   Xu, Jian ^a   Tan, Wen ^a   Qu, Chunfeng ^a   Lin, Dongxin ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOBEC3B PROTEIN; CYTIDINE DEAMINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS REPLICATION;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CYTIDINE DEAMINASE; DISEASE SUSCEPTIBILITY; FEMALE; GENE DELETION; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEINS;

EID: 84874521034     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds513     Document Type: Article

References (43)

1. El-Serag, H.B. (2011) Hepatocellular carcinoma. N. Engl. J. Med., 365, 1118-1127.
2. El-Serag, H.B. and Rudolph, K.L. (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-2576.
3. Kamatani, Y., Wattanapokayakit, S., Ochi, H., Kawaguchi, T., Takahashi, A., Hosono, N., Kubo, M., Tsunoda, T., Kamatani, N., Kumada, H. et al. (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet., 41, 591-595.
4. Zhang, H., Zhai, Y., Hu, Z., Wu, C., Qian, J., Jia, W., Ma, F., Huang, W., Yu, L., Yue, W. et al. (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat. Genet., 42, 755-758.
5. Kumar, V., Kato, N., Urabe, Y., Takahashi, A., Muroyama, R., Hosono, N., Otsuka, M., Tateishi, R., Omata, M., Nakagawa, H. et al. (2011) Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat. Genet., 43, 455-458.
6. Miki, D., Ochi, H., Hayes, C.N., Abe, H., Yoshima, T., Aikata, H., Ikeda, K., Kumada, H., Toyota, J., Morizono, T. et al. (2011) Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat. Genet., 43, 797-800.
7. Diskin, S.J., Hou, C., Glessner, J.T., Attiyeh, E.F., Laudenslager, M., Bosse, K., Cole, K., Mossé, Y.P., Wood, A., Lynch, J.E. et al. (2009) Copy number variation at 1q21.1 associated with neuroblastoma. Nature, 459, 987-991.
8. Liu, W., Sun, J., Li, G., Zhu, Y., Zhang, S., Kim, S.T., Sun, J., Wiklund, F., Wiley, K., Isaacs, S.D. et al. (2009) Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res., 69, 2176-2179.
9. Huang, L., Yu, D., Wu, C., Zhai, K., Jiang, G., Cao, G., Wang, C., Liu, Y., Sun, M., Li, Z. et al. (2012) Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. Carcinogenesis, 33, 94-100.
10. Holden, L.G., Prochnow, C., Chang, Y.P., Bransteitter, R., Chelico, L., Sen, U., Stevens, R.C., Goodman, M.F. and Chen, X.S. (2008) Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications. Nature, 456, 121-124.
11. Chiu, Y.L. and Greene, W.C. (2008) The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol., 26, 317-353.
12. Bogerd, H.P., Wiegand, H.L., Doehle, B.P., Lueders, K.K. and Cullen, B.R. (2006) APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res., 34, 89-95.
13. Narvaiza, I., Linfesty, D.C., Greener, B.N., Hakata, Y., Pintel, D.J., Logue, E., Landau, N.R. and Weitzman, M.D. (2009) Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. PLoS Pathog., 5, e1000439.
14. Bogerd, H.P., Wiegand, H.L., Hulme, A.E., Garcia-Perez, J.L., O'Shea, K.S., Moran, J.V. and Cullen, B.R. (2006) Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl. Acad. Sci. USA, 103, 8780-8785.
15. Bishop, K.N., Holmes, R.K., Sheehy, A.M., Davidson, N.O., Cho, S.J. and Malim, M.H. (2004) Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol., 14, 1392-1396.
16. Yu, Q., Chen, D., Konig, R., Mariani, R., Unutmaz, D. and Landau, N.R. (2004) APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem., 279, 53379-53386.
17. Dang, Y., Wang, X., Esselman, W.J. and Zheng, Y.H. (2006) Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family. J. Virol., 80, 10522-10533.
18. Rosler, C., Kock, J., Kann, M., Malim, M.H., Blum, H.E., Baumert, T.F. and von Weizsacker, F. (2005) APOBEC-mediated interference with hepadnavirus production. Hepatology, 42, 301-309.
19. Noguchi, C., Ishino, H., Tsuge, M., Fujimoto, Y., Imamura, M., Takahashi, S. and Chayama, K. (2005) G to A hypermutation of hepatitis B virus. Hepatology, 41, 626-633.
20. Baumert, T.F., Rosler, C., Malim, M.H. and von Weizsacker, F. (2007) Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology, 46, 682-689.
21. Kock, J. and Blum, H.E. (2008) Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. J. Gen. Virol., 89, 1184-1191.
22. Suspene, R., Guetard, D., Henry, M., Sommer, P., Wain-Hobson, S. and Vartanian, J.P. (2005) Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 102, 8321-8326.
23. Kidd, J.M., Newman, T.L., Tuzun, E., Kaul, R. and Eichler, E.E. (2007) Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet., 3, e63.
24. An, P., Johnson, R., Phair, J., Kirk, G.D., Yu, X.F., Donfield, S., Buchbinder, S., Goedert, J.J. and Winkler, C.A. (2009) APOBEC3B deletion and risk of HIV-1 acquisition. J. Infect. Dis., 200, 1054-1058.
25. Chisari, F.V. and Ferrari, C. (1995) Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol., 13, 29-60.
26. Villet, S., Ollivet, A., Pichoud, C., Barraud, L., Villeneuve, J.P., Trepo, C. and Zoulim, F. (2007) Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient. J. Hepatol., 46, 531-538.
27. Liaw, Y.F. and Chu, C.M. (2009) Hepatitis B virus infection. Lancet, 373, 582-592.
28. Cheong, J.Y., Cho, S.W., Hwang, I.L., Yoon, S.K., Lee, J.H., Park, C.S., Lee, J.E., Hahm, K.B. and Kim, J.H. (2006) Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factoralpha gene promoter polymorphisms. J. Gastroenterol. Hepatol., 21, 1163-1169.
29. Huang, H.H., Shih, W.L., Li, Y.H., Wu, C.F., Chen, P.J., Lin, C.L., Liu, C.J., Liaw, Y.F., Lin, S.M., Lee, S.D. and Yu, M.W. (2011) Hepatitis B viraemia: its heritability and association with common genetic variation in the interferon gamma signalling pathway. Gut, 60, 99-107.
30. He, X.X., Chang, Y., Jiang, H.J., Tang, F., Meng, F.Y., Xie, Q.H., Li, P.Y., Song, Y.H. and Lin, J.S. (2010) Persistent effect of IFNAR-1 genetic polymorphism on the long-term pathogenesis of chronic HBV infection. Viral Immunol., 23, 251-257.
31. Bonvin, M., Achermann, F., Greeve, I., Stroka, D., Keogh, A., Inderbitzin, D., Candinas, D., Sommer, P., Wain-Hobson, S., Vartanian, J.P. and Greeve, J. (2006) Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology, 43, 1364-1374.
32. Grivennikov, S.I., Greten, F.R. and Karin, M. (2010) Immunity, inflammation, and cancer. Cell, 140, 883-899.
33. Turelli, P., Mangeat, B., Jost, S., Vianin, S. and Trono, D. (2004) Inhibition of hepatitis B virus replication by APOBEC3G. Science, 303, 1829.
34. Peng, G., Lei, K.J., Jin, W., Greenwell-Wild, T. and Wahl, S.M. (2004) Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med., 203, 41-46.
35. Abe, H., Ochi, H., Maekawa, T., Hatakeyama, T., Tsuge, M., Kitamura, S., Kimura, T., Miki, D., Mitsui, F., Hiraga, N. et al. (2009) Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection. Hepatol. Res., 39, 1159-1168.
36. Xu, R., Zhang, X., Zhang, W., Fang, Y., Zheng, S. and Yu, X.F. (2007) Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus Bx antigen mutants and hepatocellular carcinoma. Hepatology, 46, 1810-1820.
37. Pak, V., Heidecker, G., Pathak, V.K. and Derse, D. (2011) The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B. J. Virol., 85, 8538-8547.
38. Zaranek, A.W., Levanon, E.Y., Zecharia, T., Clegg, T. and Church, G.M. (2010) A survey of genomic traces reveals a common sequencing error, RNA editing, and DNA editing. PLoS Genet., 6, e1000954.
39. Nik-Zainal, S., Alexandrov, L.B., Wedge, D.C., Van Loo, P., Greenman, C.D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L.A. et al. (2012) Mutational processes molding the genomes of 21 breast cancers. Cell, 149, 979-993.
40. Stenglein, M.D., Burns, M.B., Li, M., Lengyel, J. and Harris, R.S. (2010) APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat. Struct. Mol. Biol., 17, 222-229.
41. Ganem, D. and Prince, A.M. (2004) Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med., 350, 1118-1129.
42. Townson, J.R., Barcellos, L.F. and Nibbs, R.J. (2002) Gene copy number regulates the production of the human chemokine CCL3-L1. Eur. J. Immunol., 32, 3016-3026.
43. Vartanian, J.P., Henry, M., Marchio, A., Suspene, R., Aynaud, M.M., Guetard, D., Gonzalez, M., Battiston, C., Mazzaferro, V., Pineau, P. et al. (2010) Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog., 6, e1000928.